Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma. Int J Clin Exp Pathol. 2011; 4(7):651-60.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Brain Neoplasms
Brain Neoplasms
CD56 Antigen
CD56 Antigen
Diffusion Magnetic Resonance Imaging
Diffusion Magnetic Resonance Imaging
DNA Mutational Analysis
DNA Mutational Analysis
Female
Female
Glioblastoma
Glioblastoma
Humans
Humans
Immunohistochemistry
Immunohistochemistry
Isocitrate Dehydrogenase
Isocitrate Dehydrogenase
Male
Male
Middle Aged
Middle Aged
Mutation
Mutation
Neoplasms, Complex and Mixed
Neoplasms, Complex and Mixed
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive
Prognosis
Prognosis
Survival Analysis
Survival Analysis
Survival Rate
Survival Rate
Time Factors
Time Factors
Tumor Suppressor Protein p53
Tumor Suppressor Protein p53
Vimentin
Vimentin
authors with profiles
Kar-Ming Fung